Wall Street Zen cut shares of Sotera Health (NASDAQ:SHC – Free Report) from a strong-buy rating to a buy rating in a report published on Saturday,Wall Street Zen reports.
Other analysts also recently issued reports about the company. Citigroup increased their price target on Sotera Health from $23.00 to $25.00 and gave the company a “buy” rating in a report on Friday, August 7th. JPMorgan Chase & Co. reduced their price objective on Sotera Health from $17.00 to $15.00 and set an “underweight” rating on the stock in a research note on Wednesday. Piper Sandler reaffirmed an “overweight” rating and issued a $25.00 target price on shares of Sotera Health in a research report on Tuesday, September 8th. Barclays lowered their target price on Sotera Health from $22.00 to $20.00 and set an “overweight” rating for the company in a research note on Wednesday. Finally, Weiss Ratings downgraded Sotera Health from a “buy (b-)” rating to a “hold (c+)” rating in a report on Friday, October 23rd. Eight equities research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $20.88.
View Our Latest Analysis on Sotera Health
Sotera Health Stock Performance
NASDAQ SHC opened at $16.01 on Friday. The company has a debt-to-equity ratio of 3.04, a current ratio of 3.13 and a quick ratio of 2.55. Sotera Health has a 1-year low of $13.09 and a 1-year high of $19.85. The firm has a market capitalization of $4.57 billion, a P/E ratio of 26.68 and a beta of 1.94. The business’s 50-day simple moving average is $18.22 and its 200-day simple moving average is $16.97.
Sotera Health (NASDAQ:SHC – Get Free Report) last posted its earnings results on Tuesday, November 3rd. The company reported $0.29 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.27 by $0.02. The firm had revenue of $324.89 million during the quarter, compared to the consensus estimate of $319.86 million. Sotera Health had a net margin of 14.11% and a return on equity of 38.46%. The company’s revenue was up 4.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.26 EPS. Equities analysts predict that Sotera Health will post 0.87 EPS for the current year.
Insider Buying and Selling
In other Sotera Health news, Chairman Michael B. Jr. Petras sold 850,000 shares of the firm’s stock in a transaction that occurred on Monday, August 17th. The stock was sold at an average price of $18.50, for a total transaction of $15,725,000.00. Following the completion of the sale, the chairman owned 3,969,393 shares in the company, valued at $73,433,770.50. This trade represents a 17.64% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 15.36% of the company’s stock.
Hedge Funds Weigh In On Sotera Health
Institutional investors and hedge funds have recently made changes to their positions in the business. Integrated Wealth Concepts LLC lifted its stake in shares of Sotera Health by 3.0% in the second quarter. Integrated Wealth Concepts LLC now owns 19,443 shares of the company’s stock worth $345,000 after acquiring an additional 559 shares during the period. GAMMA Investing LLC increased its position in Sotera Health by 7.4% during the 3rd quarter. GAMMA Investing LLC now owns 10,055 shares of the company’s stock valued at $186,000 after purchasing an additional 694 shares during the period. New Mexico Educational Retirement Board increased its position in Sotera Health by 1.5% during the 3rd quarter. New Mexico Educational Retirement Board now owns 55,600 shares of the company’s stock valued at $1,028,000 after purchasing an additional 800 shares during the period. Strs Ohio increased its position in Sotera Health by 20.1% during the 1st quarter. Strs Ohio now owns 5,881 shares of the company’s stock valued at $84,000 after purchasing an additional 986 shares during the period. Finally, Fifth Third Bancorp raised its holdings in Sotera Health by 2.3% during the 3rd quarter. Fifth Third Bancorp now owns 55,641 shares of the company’s stock worth $1,029,000 after purchasing an additional 1,263 shares during the last quarter. 91.03% of the stock is currently owned by hedge funds and other institutional investors.
Sotera Health Company Profile
Sotera Health Company (NASDAQ: SHC) is a healthcare services company focused on sterilization, laboratory testing and infection prevention. Its services support manufacturers and providers across the medical device, pharmaceutical, tissue, food safety and other healthcare-related industries.
The company operates through three primary businesses. Sterigenics provides outsourced sterilization services, including ethylene oxide, gamma irradiation and electron-beam processing. Nelson Labs offers laboratory testing, analytical services and consulting for medical devices, pharmaceuticals and other healthcare products.
Read More
- Five stocks we like better than Sotera Health
- Dutch Bros Gave Wall Street What It Wanted, So Why Did the Stock Crater?
- Astera Labs Just Crushed Earnings—So Why Are Analysts Cutting Price Targets?
- Sandisk Shares Are Oversold: Bargain or Value Trap?
- IonQ’s Record Revenue Includes a Big SkyWater Boost: Does That Change the Story?
Receive News & Ratings for Sotera Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sotera Health and related companies with MarketBeat.com's FREE daily email newsletter.
